These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8707373)

  • 1. Response of mouse sarcoma-180 to cis-platin in combination with radiation & hyperthermia.
    Rao BS; Devi PU
    Indian J Med Res; 1996 Jun; 103():315-22. PubMed ID: 8707373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodality treatment using AK-2123, hydralazine, radiation & hyperthermia on a transplantable mouse tumour.
    Rao BS; Devi PU
    Indian J Med Res; 1996 Aug; 104():182-9. PubMed ID: 8840657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of mouse sarcoma-180 to bleomycin in combination with radiation and hyperthermia.
    Devi PU; Rao BS
    Strahlenther Onkol; 1993 Oct; 169(10):601-7. PubMed ID: 7694382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor and radiosensitizing effects of Withania somnifera (Ashwagandha) on a transplantable mouse tumor, Sarcoma-180.
    Devi PU; Sharada AC; Solomon FE
    Indian J Exp Biol; 1993 Jul; 31(7):607-11. PubMed ID: 8225418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy: lonidamine, hyperthermia, and chemotherapy against the RIF-1 tumor in vivo.
    Ning SC; Hahn GM
    Cancer Res; 1991 Nov; 51(21):5910-4. PubMed ID: 1718588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined effects of gamma rays, cis-diamminedichloroplatinum (CDDP) and systemic hyperthermia mastocytoma transplanted into muscle in the mouse].
    Nakamura W; Komatsu K; Kageyama K
    C R Seances Soc Biol Fil; 1985; 179(4):558-62. PubMed ID: 2938683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the response of B16F1 melanoma to fractionated radiotherapy and prolongation of survival by withaferin A and/or hyperthermia.
    Kalthur G; Pathirissery UD
    Integr Cancer Ther; 2010 Dec; 9(4):370-7. PubMed ID: 20713375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma.
    Herman TS; Teicher BA
    Cancer Res; 1988 May; 48(10):2693-7. PubMed ID: 3359430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
    Masunaga S; Ono K; Hori H; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Kasai S; Nagasawa H; Uto Y
    Radiat Med; 1998; 16(6):441-8. PubMed ID: 9929144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of mitomycin C to cis-diamminedichloroplatinum(II)/hyperthermia/radiation therapy in the FSaIIC fibrosarcoma.
    Herman TS; Teicher BA; Holden SA
    Int J Hyperthermia; 1991; 7(6):893-903. PubMed ID: 1806643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of S 180 murine tumor to bleomycin in combination with radiation and hyperthermia using micronucleus assay: a multimodality approach for therapeutic augmentation.
    Rao BS; Devi PU
    Indian J Exp Biol; 2005 Jul; 43(7):596-600. PubMed ID: 16053264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma.
    Herman TS; Teicher BA; Holden SA; Pfeffer MR; Jones SM
    Cancer Res; 1990 May; 50(9):2734-40. PubMed ID: 2139359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced therapeutic efficacy of cisplatin by combination with diethyldithiocarbamate and hyperthermia in a mouse model.
    Murthy MS; Rao LN; Khandekar JD; Scanlon EF
    Cancer Res; 1987 Feb; 47(3):774-9. PubMed ID: 3026616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
    Murata R; Horsman MR
    Int J Hyperthermia; 2004 Jun; 20(4):393-404. PubMed ID: 15204520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of antitumor response to sarcoma 45 in rats by combination of whole-body hyperthermia and interleukin-2.
    Potapnev MP; Istomin YP; Ismail-zade RS; Zhavrid EA
    Eksp Onkol; 2004 Mar; 26(1):67-70. PubMed ID: 15112583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo response of murine RIF tumors to thermochemotherapy.
    Neilan BA; Henle KJ
    J Med; 1989; 20(1):107-12. PubMed ID: 2468731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schedule dependent tumour growth delay, DNA cross-linking and pharmacokinetic parameters in target tissues with cis-diamminedichloroplatinum(II) and etanidazole with or without hyperthermia or radiation.
    Teicher BA; Pfeffer MR; Alvarez Sotomayor E; Herman TS
    Int J Hyperthermia; 1991; 7(5):773-84. PubMed ID: 1834752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumour effectiveness of hyperthermia is potentiated by local application of electric pulses to LPB tumours in mice.
    Karner KB; Lesnicar H; Cemazar M; Sersa G
    Anticancer Res; 2004; 24(4):2343-8. PubMed ID: 15330182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat-sensitive liposomes containing cisplatin and localized hyperthermia in treatment of murine tumor.
    Nishita T
    Osaka City Med J; 1998 Jun; 44(1):73-83. PubMed ID: 9834620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined effect of cis-DDP (II), OK-432 and systemic hyperthermia in ascites tumor in mice].
    Komatsu K; Nakamura W
    Nihon Gan Chiryo Gakkai Shi; 1989 Mar; 24(3):626-37. PubMed ID: 2504850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.